Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Illumina expands Billion Cell Atlas program with new AI drug developers PR Newswire - Thu Jul 16, 11:00AM CDT

Partners will use unprecedented data scale to advance more precise medicines to approval

ILMN : 186.65 (-1.89%)
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 PR Newswire - Thu Jul 9, 3:05PM CDT

SAN DIEGO , July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026....

ILMN : 186.65 (-1.89%)
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer PR Newswire - Thu Jul 9, 8:05AM CDT

New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology

ILMN : 186.65 (-1.89%)
EAT
2 Mooning Stocks Worth Investigating and 1 We Avoid StockStory - Wed Jul 8, 11:45PM CDT

2 Mooning Stocks Worth Investigating and 1 We Avoid

HLF : 11.99 (-3.07%)
ILMN : 186.65 (-1.89%)
EAT : 189.35 (+2.09%)
ILMN
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN) StockStory - Mon Jul 6, 10:33PM CDT

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)

ILMN : 186.65 (-1.89%)
ILMN
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky StockStory - Sun Jul 5, 11:31PM CDT

1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky

VTS : 15.91 (+1.60%)
ILMN : 186.65 (-1.89%)
LBRT : 23.84 (+1.62%)
WSO
3 Mid-Cap Stocks That Concern Us StockStory - Wed Jul 1, 11:37PM CDT

3 Mid-Cap Stocks That Concern Us

WSO : 371.91 (-3.44%)
ILMN : 186.65 (-1.89%)
FHN : 25.80 (+1.57%)
ILMN
Why Illumina (ILMN) Stock Is Down Today StockStory - Tue Jun 30, 1:55PM CDT

Why Illumina (ILMN) Stock Is Down Today

ILMN : 186.65 (-1.89%)
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors PR Newswire - Tue Jun 23, 8:05AM CDT

Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's Board

ILMN : 186.65 (-1.89%)
APPN
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges StockStory - Mon Jun 15, 11:33PM CDT

1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges

APPN : 26.11 (-0.38%)
ILMN : 186.65 (-1.89%)
PM : 192.98 (+1.65%)

Barchart Exclusives

AI Investors Are Becoming Pickier. 2 Stocks Still Stand Out. Barchart - Sat Jul 18, 12:30PM CDT
The easy gains from AI may be over, but few companies still stand to benefit from the next wave of AI infrastructure spending. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.